Neo Omics
Delivering high-quality multi-omics services based on advanced infrastructure
Neo Omics is a next-generation multi-omics platform that provides high-quality analysis services for cell, tissue, and liquid specimens based on advanced LC-MS proteomics equipment and fully automated end-to-end infrastructure.
Beyond simple data production, it provides foundational data for precision medicine R&D through standardized, high-quality data acquisition and analytical support.
CORE DIFFERENTIATORS
Core Differentiators
-
Core Differentiators 01
High-throughput & Cost Efficiency
Processing efficiency and a competitive cost structure suitable for large-scale samples and long-term projects
-
Core Differentiators 02
State-of-the-art LC-MS Infrastructure
High-quality proteomics analysis
based on advanced LC-MS and automated preprocessing equipment -
Core Differentiators 03
End-to-End Automation
Automation from preprocessing to analysis preparation
minimizes variability and batch effects. -
Core Differentiators 04
Cumulative Data Value
A standardized process enables continuous accumulation of customer data
and construction of data libraries.
APPLICATION AREAS
Application Areas
-
Analysis of cell, tissue, and blood specimens
Analysis services based on cell, tissue (including FFPE), and liquid specimens such as blood/plasma
-
Multi-omics data generation
Generation of multi-omics data from clinical and research specimens
-
Biomarker discovery
Biomarker discovery and data-driven research support
COLLABORATION MODEL
Collaboration Model
Neo Omics is customized according to project objectives, sample types, and analysis scope.
Beyond simple proteomics analysis, it provides integrated analytical services required for drug discovery decision-making, from large-scale data production to advanced BI analysis, spatial proteomics-based co-target discovery, and AI-based on-/off-target prediction.
-
Cell, tissue, and liquid biopsy proteomics analysis
Using an automated LC-MS-based platform, we generate large-scale proteomics data from various samples, including cells, tissues, FFPE, plasma, and serum.
Protein ID counts, PCA analysis, volcano plots, and pathway enrichment analysis are provided as standard outputs. -
Custom advanced BI analysis
We provide customized analysis and figure generation tailored to research objectives and development stages.
We support interpretation aligned with customer goals, including comparative group analysis, target protein validation, biomarker candidate identification, and drug response interpretation.
ANALYTICAL SYSTEM
Research Infrastructure
Together with Oncocross, we create new opportunities in drug discovery, diagnostics,
and data-driven expansion.
Let's Build the Next Possibility in Precision Medicine